PORTFOLIO

CareNet, Inc.

CareNet, Inc.(TSE 2015)

In addition to providing physicians and medical professionals with helpful information for day-to-day clinical practice via the internet, CareNet, Inc. provides pharmaceutical companies with solutions for effectively carrying out activities for disseminating pharmaceuticals information.

SanBio Co., Ltd.

SanBio Co., Ltd.(TSE 4592)

SanBio Co., Ltd. develops, manufactures, and sells regenerative cell drugs for treating central nervous system injuries or diseases such as stroke or traumatic brain injury. Currently the company is aiming to realize breakthrough therapeutic drugs for treating chronic- phase stroke and traumatic brain injury.

Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

Possessing a powerful therapeutic drug creation platform based on the genome editing technology CRISPR, this bio-tech company aims to develop breakthrough therapeutic drugs for treating genetic diseases, which are said to number in excess of 6,000.

CellGenTech, Inc.

CellGenTech, Inc.

CellGenTech carries out practical development of adipocyte drugs for use in gene therapies incorporating therapeutic protein genes for the treatment of intractable diseases that occur due to congenital enzyme or functional protein deficiencies.